Scinovex
articleTop 10% cited

Clinical, social, and ethical implications of changing life expectancy in Down syndrome

Developmental Medicine & Child Neurology · 2004 · Vol. 46(04) · pp. 282–6
A.H. BittlesEJ Glasson

Abstract

Between 1 and 4% of the populations of developed nations are diagnosed with learning disability. In Australia, an estimated 1.9% of the population exhibit learning disability either as a primary disability or as a secondary condition, and approximately half of these people require continuing support in daily living, including mobility, self-care, and socialization. After improvements in basic public health measures, life expectancy in most developed nations increased over the course of the 20th century, and this trend included people with learning disability. Thus, by the end of that century, the survival estimates for people with mild learning disability living in developed countries was 70 years, and nearly 60 years of age for those with severe learning disability.

Down syndrome and intellectual disability researchChronic Disease Management StrategiesHealthcare innovation and challengesLife expectancyPsychologyMEDLINEMedicineGerontologyPolitical scienceEnvironmental health

MeSH terms

Actuarial AnalysisAgingAustraliaDown SyndromeFemaleHealth ServicesHumansLife ExpectancyMaleComorbiditySurvival Analysis

Funding

  • Edith Cowan University
Citations
356
FWCI
8.29
field-weighted impact
References
73
Percentile
98%
vs. same field & year
Citations per year
References
The prevalence of mental retardation: a critical review of recent literature
Developmental Medicine & Child Neurology · 1997 · 455 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Clinical, social, and ethical implications of changing life expectancy in Down syndrome · Scinovex